Brain tumors are abnormal growths of cells within the brain or surrounding tissues. These masses can be benign (non-cancerous) or malignant (cancerous), but both types can cause significant health issues. Depending on the tumor’s size and position, patients may experience headaches, seizures, changes in cognitive function, and more.
Recent medical research has raised concerns about a potential link between the use of certain medications and an increased risk of brain tumors. One medication under scrutiny is Depo-Provera, a widely used form of birth control. A Depo-Provera brain tumor attorney at the Shapiro Legal Group, PLLC is prepared to assist you today.
What Is Depo-Provera and How Does It Work?
Depo-Provera is a popular injectable contraceptive for women seeking long-term birth control. Administered every 12 weeks, this synthetic hormone works by suppressing ovulation and altering the uterine environment to prevent pregnancy.
The active ingredient, medroxyprogesterone acetate, mimics the natural hormone progesterone. By interacting with the body’s endocrine system, Depo-Provera prevents the release of eggs, thickens cervical mucus, and changes the uterine lining, creating multiple barriers against conception.
Is There a Link Between Brain Tumors and Depo-Provera?
Recent research has uncovered a concerning association between prolonged use of certain progestogen-based medications, including Depo-Provera, and an increased risk of brain tumors—specifically intracranial meningiomas. These tumors form around the brain and spinal cord, leading to complications like vision and hearing loss and physical weakness.
A study published in the British Medical Journal examined data from over 18,000 women who had undergone surgery to remove intracranial meningiomas. The findings were startling: women who had used Depo-Provera for more than a year were nearly 5.6 times more likely to develop a meningioma requiring surgery than those who had not used the medication. With millions of women relying on Depo-Provera and similar medications, the implications of this study are far-reaching and potentially life-altering.
Seeking Compensation for Depo-Provera-Related Brain Tumors
In light of these findings, many women who have developed brain tumors after using Depo-Provera are exploring their legal options. Lawsuits filed against Pfizer, the medication’s manufacturer, allege that the company failed to warn patients and healthcare providers about this serious risk. Now, patients are seeking compensation for medical expenses, lost wages, pain and suffering, and other damages resulting from these diagnoses.
To be eligible for a Depo-Provera lawsuit, potential plaintiffs must meet the following criteria:
- They must have used the brand-name Depo-Provera (manufactured by Pfizer), depo-SubQ Provera, or an authorized generic version.
- They must have used the eligible medication at least twice.
- They must have been diagnosed with a meningioma or brain tumor after using the medication.
Are you unsure whether you qualify for a Depo-Provera lawsuit? Your optimal course of action is to speak with a lawyer who represents these claims. An attorney can assess whether you meet the eligibility criteria based on the latest guidance and help you pursue the settlement that you need to recover.
Get Professional Legal Support for Your Depo-Provera Case
If you are concerned about the potential link between Depo-Provera and brain tumors, you need clear answers and strong legal support. Shapiro Legal Group, PLLC has the knowledge and experience that you need to seek justice and fair compensation.
Our attorneys will examine the latest research, assess your situation, and advise you on potential legal recourse. Call us at our toll-free number (800) 220-0984 for a comprehensive case evaluation and start your claim with the help of a Depo-Provera lawsuit attorney.